Patient Platforms
This carefully curated collection features companies building the technological foundations that will power innovation for decades to come. Our analysts have identified businesses creating essential infrastructure in genomics, AI, robotics, and advanced computing—platforms that could define their industries and generate substantial long-term returns.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Intuitive Surgical, Inc.
ISRG
Current price
$479.20
Dominates the robotic-assisted surgery market with its da Vinci platform, a foundational technology that continues to expand its applications and long...
Dominates the robotic-assisted surgery market with its da Vinci platform, a foundational technology that continues to expand its applications and long-term potential.
ASML Holding NV
ASML
Current price
$743.61
Holds a monopoly on the critical EUV lithography machines required to manufacture the world's most advanced semiconductors, making it a foundational p...
Holds a monopoly on the critical EUV lithography machines required to manufacture the world's most advanced semiconductors, making it a foundational platform for the entire tech industry.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
We've identified companies building fundamental technological infrastructure that entire industries will depend on. These aren't simple product makers but ecosystem creators in genomics, AI, robotics, and advanced computing with deep intellectual property moats and multi-year growth runways.
What You Need to Know
This is a long-horizon investment approach. These companies are creating complex, integrated systems that may take years to fully mature but could dominate their industries once established. The rapid integration of AI is accelerating development timelines and expanding potential applications.
Why These Stocks
Each company selected is an undisputed technology leader with significant intellectual property and a platform others build upon. They represent the essential building blocks of future technological revolutions, with innovations that will likely power the next wave of scientific and industrial advancement.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+80.72%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 80.72% over the next year.
Stocks Rated Buy by Analysts
13 of 17 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
The Future Belongs to Platform Builders
These companies aren't just creating products—they're building the essential infrastructure that entire industries will depend on for decades. They're laying the groundwork for technologies we can barely imagine today.
AI is Accelerating Everything
The rapid integration of artificial intelligence is dramatically speeding up development cycles for these platform technologies. What might have taken a decade is now happening in years, creating potential growth catalysts.
Intellectual Property Powerhouses
These companies have built deep moats of intellectual property and technical expertise that can't be easily replicated. Their fundamental technologies are protected by patents and know-how that keeps competitors at bay.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Orphan Drug Moats: Leaders In Rare Disease
The FDA's rejection of PTC Therapeutics' drug for a rare genetic disorder has delayed a new treatment option and created a significant setback for the company. This regulatory decision strengthens the competitive position of companies with already-approved therapies for rare diseases, highlighting the value of a proven drug portfolio.
Nvidia's China Chip Pivot
Nvidia is developing a new, compliant AI chip for China, aiming to recapture market share lost to U.S. export controls. This strategic pivot creates a ripple effect, potentially benefiting the entire semiconductor supply chain that supports the production and deployment of this advanced hardware.
Navigating The Autonomous Driving Shakeout
A class-action lawsuit against Tesla regarding its Full Self-Driving claims puts the company's marketing and technology under intense scrutiny. This legal challenge could boost demand for competing autonomous driving technologies, creating opportunities for companies that supply advanced sensors and software.
Frequently Asked Questions
Everything you need to know about the product and billing.